Bettina Sandmeier1, Veronika K Jäger1, Gabriella Nagy2, Patricia E Carreira3, Alexandar Tzankov4, Malgorzata Widuchowska5, Milos Antic6, Oliver Distler6, Helena Reichert7, Jörg H W Distler7, Ulrich A Walker1, Thomas Hügle8. 1. Department of Rheumatology, University Hospital Basel, Switzerland. 2. Department of Rheumatology and Immunology, University of Pécs, Hungary. 3. Servicio de Reumatologia, Hospital Universitario 12 de Octubre, Madrid, Spain. 4. Institute of Pathology, University Hospital Basel, Switzerland. 5. Department of Internal Medicine and Rheumatology, Medical University of Silesia, Katowice, Poland. 6. Division of Rheumatology, University Hospital Zurich, Zurich, Switzerland. 7. Department of Internal Medicine 3, University of Erlangen-Nuremberg, Germany. 8. Department of Rheumatology, University Hospital Basel, Switzerland. thomas.huegle@unibas.ch.
Abstract
OBJECTIVES: Subclinical organ pathology occurs regularly in systemic sclerosis (SSc) and affects correct prognosis as well as treatment choices. We aimed to evaluate autopsy data for organ involvement with subsequent correlation to clinical data in order to assess discrepancies in pathological and clinical findings in SSc. METHODS: A standardised autopsy questionnaire from diseased patients registered in the European Scleroderma Trials and Research group (EUSTAR) cohort was analysed on cause of death and various manifestations in different organ systems. Clinical data obtained from the EUSTAR database of the corresponding patients including cause of death and disease manifestations of lung, heart, kidney, gastrointestinal, skin or musculoskeletal organ involvement were retrospectively analysed and compared to autopsy data. RESULTS: 11 patients (6 women, 5 male) aged between 23 and 84 were included. Cause of death defined by pathologist and clinician were identical in 9/11 cases. In 8 individuals, cause of death was related to heart and lung pathologies. Heart and lung involvement (both 10/11) were the most frequently detected organ involvement at autopsy. Here, myocardial fibrosis occurred in 66% and lung fibrosis in 50% of the patients. Clinically, diastolic function abnormalities (6/11), conduction block (4/11), reduced DCLO (6/11) and dyspnea (8/11) were the most prevalent cardiopulmonary findings. For heart and renal involvement we found higher prevalence in autopsy than by clinical diagnosis. Especially myocardial fibrosis and renal arteriosclerosis were only obtained by autopsy in several individuals. CONCLUSIONS: Clinical diagnostic procedures are limited in detection of end-organ damage, especially for cardiac involvement. All the more post mortem examinations are needed for quality verification of clinical diagnosis and might help as to better understand the disease processes as well as to improve patient care.
OBJECTIVES: Subclinical organ pathology occurs regularly in systemic sclerosis (SSc) and affects correct prognosis as well as treatment choices. We aimed to evaluate autopsy data for organ involvement with subsequent correlation to clinical data in order to assess discrepancies in pathological and clinical findings in SSc. METHODS: A standardised autopsy questionnaire from diseased patients registered in the European Scleroderma Trials and Research group (EUSTAR) cohort was analysed on cause of death and various manifestations in different organ systems. Clinical data obtained from the EUSTAR database of the corresponding patients including cause of death and disease manifestations of lung, heart, kidney, gastrointestinal, skin or musculoskeletal organ involvement were retrospectively analysed and compared to autopsy data. RESULTS: 11 patients (6 women, 5 male) aged between 23 and 84 were included. Cause of death defined by pathologist and clinician were identical in 9/11 cases. In 8 individuals, cause of death was related to heart and lung pathologies. Heart and lung involvement (both 10/11) were the most frequently detected organ involvement at autopsy. Here, myocardial fibrosis occurred in 66% and lung fibrosis in 50% of the patients. Clinically, diastolic function abnormalities (6/11), conduction block (4/11), reduced DCLO (6/11) and dyspnea (8/11) were the most prevalent cardiopulmonary findings. For heart and renal involvement we found higher prevalence in autopsy than by clinical diagnosis. Especially myocardial fibrosis and renal arteriosclerosis were only obtained by autopsy in several individuals. CONCLUSIONS: Clinical diagnostic procedures are limited in detection of end-organ damage, especially for cardiac involvement. All the more post mortem examinations are needed for quality verification of clinical diagnosis and might help as to better understand the disease processes as well as to improve patient care.
Authors: George Hung; Valentina Mercurio; Steven Hsu; Stephen C Mathai; Ami A Shah; Monica Mukherjee Journal: Curr Rheumatol Rep Date: 2019-12-07 Impact factor: 4.592
Authors: Cosimo Bruni; Maya H Buch; Daniel E Furst; Giacomo De Luca; Aleksandra Djokovic; Raluca B Dumitru; Alessandro Giollo; Marija Polovina; Alexia Steelandt; Kostantinos Bratis; Yossra Atef Suliman; Ivan Milinkovic; Anna Baritussio; Ghadeer Hasan; Anastasia Xintarakou; Yohei Isomura; George Markousis-Mavrogenis; Lorenzo Tofani; Sophie Mavrogeni; Luna Gargani; Alida Lp Caforio; Carsten Tschöpe; Arsen Ristic; Karin Klingel; Sven Plein; Elijah R Behr; Yannick Allanore; Masataka Kuwana; Christopher P Denton; Dinesh Khanna; Thomas Krieg; Renzo Marcolongo; Ilaria Galetti; Elisabetta Zanatta; Francesco Tona; Petar Seferovic; Marco Matucci-Cerinic Journal: J Scleroderma Relat Disord Date: 2021-10-26
Authors: D Farge; R K Burt; M-C Oliveira; E Mousseaux; M Rovira; Z Marjanovic; J de Vries-Bouwstra; N Del Papa; R Saccardi; S J Shah; D C Lee; C Denton; T Alexander; D G Kiely; J A Snowden Journal: Bone Marrow Transplant Date: 2017-05-22 Impact factor: 5.483
Authors: Jessica Meijs; Anne A Schouffoer; Nina Ajmone Marsan; Lucia J M Kroft; Theo Stijnen; Maarten K Ninaber; Tom W J Huizinga; Theodora P M Vliet Vlieland; Jeska K de Vries-Bouwstra Journal: RMD Open Date: 2016-03-15